Home › Acute Lymphoblastic Leukemia
Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia na nagre-recruit sa U.S.
134 pag-aaral para sa Acute Lymphoblastic Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX28 pag-aaral
- New York City, NY24 pag-aaral
- Seattle, WA21 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Chicago, IL19 pag-aaral
- Atlanta, GA18 pag-aaral
- Memphis, TN16 pag-aaral
- Philadelphia, PA16 pag-aaral
- Washington, DC16 pag-aaral
- Boston, MA15 pag-aaral
- Los Angeles, CA14 pag-aaral
- Durham, NC13 pag-aaral
- Mountain View, CA13 pag-aaral
- Cincinnati, OH12 pag-aaral
- Minneapolis, MN12 pag-aaral
- Columbus, OH11 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Tampa, FL10 pag-aaral
- Baltimore, MD9 pag-aaral
- Edison, NJ9 pag-aaral
- Portland, OR9 pag-aaral
- Aurora, CO8 pag-aaral
- Charlotte, NC8 pag-aaral
- Miami, FL8 pag-aaral
- Nashville, TN8 pag-aaral
- San Antonio, TX8 pag-aaral
- Denver, CO7 pag-aaral
- Birmingham, AL7 pag-aaral
- Cleveland, OH7 pag-aaral
- Milwaukee, WI6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- St. Louis, MO6 pag-aaral
- Queens, NY6 pag-aaral
- Phoenix, AZ6 pag-aaral
- Oklahoma City, OK6 pag-aaral
- Detroit, MI6 pag-aaral
- San Diego, CA6 pag-aaral
- Indianapolis, IN5 pag-aaral
- Norfolk, VA5 pag-aaral
- The Bronx, NY5 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona6 pag-aaral
- Arkansas5 pag-aaral
- California40 pag-aaral
- Colorado12 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia10 pag-aaral
- Florida19 pag-aaral
- Georgia19 pag-aaral
- Hawaii3 pag-aaral
- Illinois20 pag-aaral
- Indiana6 pag-aaral
- Iowa5 pag-aaral
- Kansas5 pag-aaral
- Kentucky4 pag-aaral
- Louisiana6 pag-aaral
- Maine3 pag-aaral
- Maryland16 pag-aaral
- Massachusetts15 pag-aaral
- Michigan8 pag-aaral
- Minnesota14 pag-aaral
- Mississippi3 pag-aaral
- Missouri6 pag-aaral
- Nebraska4 pag-aaral
- Nevada3 pag-aaral
- New Jersey11 pag-aaral
- New Mexico3 pag-aaral
- New York32 pag-aaral
- North Carolina21 pag-aaral
- Ohio21 pag-aaral
- Oklahoma8 pag-aaral
- Oregon10 pag-aaral
- Pennsylvania21 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina5 pag-aaral
- South Dakota3 pag-aaral
- Tennessee22 pag-aaral
- Texas30 pag-aaral
- Utah10 pag-aaral
- Virginia9 pag-aaral
- Washington22 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
Edad 12 hanggang 78 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03802695Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07572136A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Nagre-recruit
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06904066A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Nagre-recruitPhase 2
6 Months · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06144606Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Nagre-recruitObservasyonal na pag-aaral
4 Weeks – 18 Years · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06529575Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06819475A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Nagre-recruitPhase 1
Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06173518A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
Nagre-recruitPhase 2
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05884333CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Nagre-recruitPhase 2
Edad 3 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07328503Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Nagre-recruitPhase 1/2
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT03104491Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07586618Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Nagre-recruitPhase 1
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06408194Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Hanggang edad 50 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07257419Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Nagre-recruitPhase 1
1 Day – 21 Years · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT05857969Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06227026The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.